NYSE:ZTSPharmaceuticals
Zoetis (ZTS) Joins The Russell Midcap, Is The Stock Cheap Now?
Index reshuffle puts Zoetis in the midcap spotlight
Zoetis (ZTS) is back in focus after being added to the Russell Midcap Index and related style benchmarks, while simultaneously exiting several Russell Top 200 indices. This shift can influence index-tracking fund flows.
This reclassification follows a period where Zoetis shares declined 2% over the past month and roughly 36% over the past 3 months, leaving the stock down about 40% year to date and roughly 50% over the past year.
See our...